We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 153

Beyond gender biaslessons from the female libido drug’s path to approval
  • Nelson Mullins Riley & Scarborough LLP
  • USA
  • March 21 2014

Female libido drug candidate flibanserin has rekindled a debate about gender bias in the Food and Drug Administration's drug approval process. The


Robin Shea
  • Constangy Brooks Smith & Prophete LLP

Laura Bentele
  • Armstrong Teasdale LLP

Sally Albertazzie
  • Steptoe & Johnson LLP